EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden

G Wagenius,A Vikström,A Berglund,S Salomonsson,G Bencina,X Hu,D Chirovsky,H Brunnström,S Ekman

doi:10.1016/j.jtho.2022.07.655

EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden

G Wagenius, A Vikström + Show 7 more

Open Access

https://doi.org/10.1016/j.jtho.2022.07.655

Copy DOI

Journal: Journal of Thoracic Oncology	Publication Date: Sep 1, 2022
License type: publisher-specific-oa

Affiliation: Karolinska University Hospital, Linköping University Hospital, Epistar (Taiwan), MSD (Sweden), MSD (Spain), MSD (United States), Lund University

#Advanced Non-Small Cell Lung Cancer #Lung Cancer In Sweden + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Since the introduction of immune-oncology therapies (IO) as treatment for advanced non-small cell lung cancer (aNSCLC), the treatment landscape for patients with aNSCLC has evolved significantly. This study aims to describe the PD-L1 testing rates, treatment patterns and associated real-world outcomes in the Swedish setting.

Full Text